Conference Day Two | Thursday, October 2

Explore the full event guide to gain insights into the 3 days of content, speakers & partners at this year's summit!

Learn More Here

7:45 am Check-in & Coffee

Streamlining Regulatory Strategies & Advancing Cell Delivery for Successful iPSC Therapy Development

8:30 am Panel Discussion: Understanding Evolving Frameworks & Addressing Regulatory Expectations Towards iPSC Based Therapies

  • Eric Law Head of Chemistry, Manufacturing Controls & Regulatory Affairs, Century Therapeutics
  • Rajesh Thangapazham Global Regulatory Strategy Lead, Vertex Pharmaceuticals
  • Azadeh Golipour Senior Vice President & Head of Technical Operations, GC Therapeutics
  • Allen Feng Founder & Chief Scientific Officer, HebeCell

Synopsis

For session details, view the full event guide.

9:30 am Case Study: Discussing the Regulatory Pathway to Clinic

  • Eric Law Head of Chemistry, Manufacturing Controls & Regulatory Affairs, Century Therapeutics

Synopsis

For session details, view the full event guide.

10:00 am Session Reserved for Fujifilm

10:30 am Refining the Path to Delivering Cells to Patients

  • Doris taylor Chief Executive Officer & Co-Founder, Organamet

Synopsis

For session details, view the full event guide.

11:00 am Morning Break & Networking

Preclinical Track

Demonstrating Safety for iPSC-Derived Therapies to Ensure a Smooth Path to Clinic

12:00 pm Roundtable Discussion: Analyzing Different Approaches to Toxicology Assays

Synopsis

For session details, view the full event guide.

Selecting the Right Conditions to Nurture Desired iPSC Differentiation

12:30 pm Accurately Recapitulating T-Cell Development for Autoimmune & Oncology Applications

  • Ran Jing Instructor, Harvard Medical School, Boston Children’s Hospital

Synopsis

For session details, view the full event guide.

Process Development & CMC Track

Enabling Scalable & Reliable Manufacturing of iPSC Derived Cells for Broad Therapeutic Impact

12:00 pm Scale Generation of PSC-derived Natural Killer Cells Utilizing Suspension Culture

Synopsis

For session details, view the full event guide.

12:30 pm Standardizing iPSC Differentiation to Improve Reproducibility in Manufacturing

  • Jason Mills Senior Director, Process Research & Development, Century Therapeutics

Synopsis

For session details, view the full event guide.

1:00 pm Lunch

2:00 pm Evaluating the Impact of Cell Culture Environments on iPSC Differentiation

Synopsis

For session details, view the full event guide.

2:30 pm Advanced Technologies for Engineering iPSC-Derived Tissues & Organs

Synopsis

For session details, view the full event guide.

Advancing Cell Characterization Techniques & Parameters for Validation of Processes

2:00 pm Defining Parameters to Assess the Quality of Desired End Cell Type

  • Lina Sui Senior Director, Process and Analytical Development, Sana Biotechnology

Synopsis

For session details, view the full event guide.

2:30 pm Finding the Right Balance when Monitoring iPSCs

Synopsis

For session details, view the full event guide.

3:00 pm Afternoon Break

Leveraging iPSCs Beyond Cellular Therapies

3:30 pm Advancing Cancer Modeling with iPSCs: Current Approaches & Opportunities

Synopsis

For session details, view the full event guide.

4:00 pm Harnessing iPSCs for Drug Development, Applications in Drug Screening & Hit Identification

Synopsis

For session details, view the full event guide.

4:30 pm Closing Remarks

4:40 pm End of the 5th iPSC Drug Development Summit

Day One
Register